A Request from YOUR MS Peer, asking you to HELP us (MS Views and News) Make an Impact! 💙
Dear MS Peers and to all else, I, Stuart Schlossman, Your MS Peer, founded MS Views and News in…
video: Optic Neuritis MRI Orbits Findings
No excerpt…
Stuart Schlossman
video: Remyelination in MS
No excerpt…
Stuart Schlossman
video: Curious about early MS symptoms doctors often miss?
No excerpt…
Stuart Schlossman
video: Multiple Sclerosis Progression, Independent from relapse Activity
by Aaron Boster, MD…
Stuart Schlossman
Living with MS: Sometimes One Really Is the Loneliest Number
By: Dr. Vicky Leavitt is a neuropsychologist As a neuropsychologist and neuroscience researcher, I have been studying the brain for…
Stuart Schlossman
MOGAD has unique immune signature distinct from MS: Study
by Margarida Maia, PhD | November 18, 2025 Multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) share similar symptoms…
Stuart Schlossman
FDA approves generic version of Vumerity for relapsing MS
by Patricia Inacio, PhD | November 18, 2025 Zydus capsules to be used for same indications as brand-name treatment Zydus Lifesciences received final approval…
Stuart Schlossman
New Biological Mechanism Boosts Myelin Production in the Brain
TAU researchers discover how to increase myelin production — a finding that could aid treatments for Alzheimer’s and multiple sclerosis.…
Stuart Schlossman
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar Basel, November 17, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the…
Stuart Schlossman
